• Cytomegalovirus (CMV) Antibody, IgG
  • Bacterial Culture, Lower Respiratory
  • Androgen insensitivity syndrome
  • Tissue Transglutaminase (tTG) Antibody, IgA
  • Glucose Tolerance Test, 2 Hour Post-75g Oral Ingestion
  • Hepatitis D Virus (HDV) RNA, Molecular Method
  • Wound Pathogen Panel with Antibiotic Resistance by Molecular
  • Trichomonas vaginalis, Culture
  • Magnesium/Creatinine Ratio, Random, Urine
  • Beta-2 Microglobulin, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Serum
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Serum
Medical Test

Overview
Access to Cancer Antigen (CA) 19-9, Serum is restricted.